The CCA is your source for current and reliable research. Check out these newly published research articles:
CCA partners with McMaster University on gluten free on campus (May 2021)
Access to gluten-free diet across Canadian Universities and Colleges
Students currently attending a Canadian University or College who may have been diagnosed with CD, non-celiac-gluten sensitivity (NCGS) or follow a gluten-free diet (GFD) for another reason are invited to participate.
As the number of individuals adhering to a gluten-free diet rises, there is a need to identify barriers that students adopting a GFD face on campus at Canadian universities to ease their access to viable gluten-free options. Our hope is that this survey will help us understand more about the challenges faced by students adopting a GFD in Canada, further contributing towards more education in the near future.
This survey will take approximately 3 minutes to complete. This collaborative research study survey conducted by clinicians and researchers from McMaster University and the Canadian Celiac Association.
Current and emerging trends in coeliac disease. (November 24, 2020)
More turkey dinners for people with celiac disease? (October 2020)
Researchers find combo of tryptophan with probiotics may help them heal
The risk of contracting COVID-19 is not increased in patients with celiac disease
Zhen J1, Stefanolo JP2, Temprano MP2, Tedesco S1, Seiler C1, Caminero A1, de-Madaria E3, Montoro Huguet M4,5, Vivas S6, Niveloni S2, Bercik P1, Smecuol E2,Uscanga L7, Trucco E8, Lopez V8, Olano C8, Mansueto P9, Caroccio A9, Green PH10,Day AS11, Tye-Din JA12, Bai JC2, Ciacci C13, Verdu EF1, Lebwohl B10, Pinto-Sanchez MI1
This past spring CCA along with many patient organizations across the world participated in a study of patients with celiac disease (CeD) and their experience and knowledge of COVID-19. Numerous studies suggest that celiac disease (CeD) is associated with an increased risk of respiratory infections. However, how it relates to the risk of COVID-19 is unknown. To address this gap, the investigators conducted a cross-sectional study to evaluate whether patients with self-reported CeD are at an increased risk of contracting COVID-19. Patients were asked to complete an online survey and a total of 18,000 individuals participated. The Canadian celiac community represented the vast majority of participants in the study and we thank them for their participation. The study concluded that patients with CeD have similar odds of contracting COVID-19 and may not need to take additional precautions to prevent exposure aside from the recommended to the general public. Longitudinal studies employing repeated measurements will contribute to a better understanding on whether the risk of contracting COVID-19 in CeD changes over time.
It will be published in Clinical Gastroenterology and Hepatology
-October 11, 2020
CCA surveyed thousands of Canadians with celiac to see what they know about oats.
-May 2020
Organic pollutants and increased risk of celiac disease
-May 2020
In a systematic review and meta-analysis, the study found an increased risk of IBD in patients with celiac disease and increased risk of celiac disease in patients with IBD, compared with other patient populations. High-quality prospective cohort studies are needed to assess the risk of celiac disease-specific and IBD-specific biomarkers in patients with IBD and celiac disease.
Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis
CCA Research grant winner James King lead an international meta-analysis on the growth of celiac disease.
Click here for video recording of his study results during the CCA National conference.
April 2020
Patients With Celiac Disease on Gluten-Free Diets Consume Measurable Amounts of Gluten – March 2020
This study received funding from CCA’s James A. Campbell Research Fund. Dr. Donald Duerksen. The Doggie Bag Study
Sheffield researchers confirm coeliac disease can damage the brain – February 2020
Undeclared Gluten in Products Containing Gluten-Free Oats – Canadian Food Inspection Agency Survey, published November 2019
European Clinical Practice Guidelines for Celiac Disease (ESPHGAN) – October 2019
Takeda acquires global license for investigational therapy for celiac disease following positive 2A clinical trial – October, 2019
Predicting Instestinal Healing – October, 2019
Cross-Contact Study – Do families really need two toasters – October 2019
Metabolism of wheat proteins by intestinal microbes: Implications for wheat related disorders – September 2019
Silent celiac disease common in relatives of patients – September, 2019
Celiac disease: should we care about microbes? – August 2019
Survey of the initial management of celiac disease antibody tests by ordering physicians
Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patient – March 2019
Assessment of the knowledge of the gluten-dree diet amongst food handlers in health care institution care facilities – March 2019
Normalization Time of Celiac Serology in Children on a Gluten-free Diet
Genetic Overlap Between Autoimmune Disease and NHL Not Supported by Genome-Wide Association Study
World’s first diagnostic blood test for celiac disease in sight
Why people with celiac disease suffer so soon after eating gluten
New study calls for screening of family members of celiac disease patients
